AMP-18 targets p21 to maintain epithelial homeostasis

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Chen, Peili ^a   Li, Yan Chun ^a   Toback, F Gary ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTRUM MUCOSAL PROTEIN 18; CELL PROTEIN; PROTEIN P21; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CASPASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1A; GKN1 PROTEIN, HUMAN; PEPTIDE HORMONE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DAMAGE; CELL PROLIFERATION; CELL PROTECTION; CELL REGENERATION; COLITIS; CONTROLLED STUDY; HOMEOSTASIS; INHIBITION KINETICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RAT; STOMACH EPITHELIUM; ANIMAL; CELL FRACTIONATION; CELL NUCLEUS; CHEMICALLY INDUCED; DRUG EFFECTS; EPITHELIUM CELL; HUMAN; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; APOPTOSIS; CASPASE 3; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; COLITIS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EPITHELIAL CELLS; HOMEOSTASIS; HUMANS; MICE; PEPTIDE HORMONES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84928678614     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125490     Document Type: Article

References (62)

1. Chen P, Kartha S, Bissonnette M, Hart J, Toback FG. AMP-18 facilitates assembly and stabilization of tight junctions to protect the colonic mucosal barrier. Inflamm Bowel Dis. 2012; 18: 1749-1759. doi: 10.1002/ibd.22886 PMID: 22271547
2. Martin TE, Powell CT, Wang Z, Bhattacharyya S, Walsh-Reitz MM, Agarwal K, et al. A novel mitogenic protein that is highly expressed in cells of the gastric antrum mucosa. Am J Physiol Gastrointest Liver Physiol. 2003; 285: G332-343. PMID: 12851218
3. Toback FG, Walsh-Reitz MM, Musch MW, Chang EB, Del Valle J, Ren H, et al. Peptide fragments of AMP-18, a novel secreted gastric antrum mucosal protein, are mitogenic and motogenic. Am J Physiol Gastrointest Liver Physiol. 2003; 285: G344-353. PMID: 12851219
4. Walsh-Reitz MM, Huang EF, Musch MW, Chang EB, Martin TE, Kartha S, et al. AMP-18 protects barrier function of colonic epithelial cells: role of tight junction proteins. Am J Physiol Gastrointest Liver Physiol. 2005; 289: G163-171. PMID: 15961882
5. Chen P, Lingen M, Sonis ST, Walsh-Reitz MM, Toback FG. Role of AMP-18 in oral mucositis. Oral Oncol. 2011; 47: 831-839. doi: 10.1016/j.oraloncology.2011.06.012 PMID: 21737340
6. Wu X, Chen P, Sonis S, Lingen M, Berger A, Toback F. A novel peptide to treat oral mucositis blocks endothelial and epithelial cell apoptosis. Int J Radiat Oncol Biol Phys. 2012; 83: e409-415. doi: 10.1016/j.ijrobp.2012.01.006 PMID: 22420966
7. Edelblum KL, Turner JR. The tight junction in inflammatory disease: communication breakdown. Curr Opin Pharmacol. 2009; 9: 715-720. doi: 10.1016/j.coph.2009.06.022 PMID: 19632896
8. Salim SY, Soderholm JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis. 2011; 17: 362-381. doi: 10.1002/ibd.21403 PMID: 20725949
9. McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis. 2009; 15: 100-113. doi: 10.1002/ibd.20539 PMID: 18623167
10. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000; 68: 7010-7017. PMID: 11083826
11. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut. 2004; 53: 987-992. PMID: 15194649
12. Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 2002; 122: 867-874. PMID: 11910337
13. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001; 411: 342-348. PMID: 11357141
14. Sears RC, Nevins JR. Signaling networks that link cell proliferation and cell fate. J Biol Chem. 2002; 277: 11617-11620. PMID: 11805123
15. Edelblum KL, Yan F, Yamaoka T, Polk DB. Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm Bowel Dis. 2006; 12: 413-424. PMID: 16670531
16. Goretsky T, Dirisina R, Sinh P, Mittal N, Managlia E, Williams DB, et al. p53 mediates TNF-induced epithelial cell apoptosis in IBD. Am J Pathol. 2012; 181: 1306-1315. doi: 10.1016/j.ajpath.2012.06.016 PMID: 22863952
17. Iwamoto M, Koji T, Makiyama K, Kobayashi N, Nakane PK. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol. 1996; 180: 152-159. PMID: 8976873
18. Strater J, Wellisch I, Riedl S, Walczak H, Koretz K, Tandara A, et al. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology. 1997; 113: 160-167. PMID: 9207274
19. Araki Y, Mukaisyo K, Sugihara H, Fujiyama Y, Hattori T. Increased apoptosis and decreased proliferation of colonic epithelium in dextran sulfate sodium-induced colitis in mice. Oncol Rep. 2010; 24: 869-874. PMID: 20811666
20. Vetuschi A, Latella G, Sferra R, Caprilli R, Gaudio E. Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci. 2002; 47: 1447-1457. PMID: 12141799
21. Wang Y, Wang L, Iordanov H, Swietlicki EA, Zheng Q, Jiang S, et al. Epimorphin(-/-) mice have increased intestinal growth, decreased susceptibility to dextran sodium sulfate colitis, and impaired spermatogenesis. J Clin Invest. 2006; 116: 1535-1546. PMID: 16710473
22. Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008; 214: 149-160. PMID: 18161752
23. Rutgeerts P, Van Assche G, Vermeire S. Optimizing anti-TNF treatment in inflammatory bowel disease. Gastroenterology. 2004; 126: 1593-1610. PMID: 15168370
24. Capaldo CT, Nusrat A. Cytokine regulation of tight junctions. Biochim Biophys Acta. 2009; 1788: 864-871. doi: 10.1016/j.bbamem.2008.08.027 PMID: 18952050
25. Marchiando AM, Shen L, Graham WV, Weber CR, Schwarz BT, Austin JR 2nd, et al. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol. 2010; 189: 111-126. doi: 10.1083/jcb.200902153 PMID: 20351069
26. Sipos F, Molnar B, Zagoni T, Berczi L, Tulassay Z. Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel diseases: ulcerative colitis shows specific p53- and EGFR expression alterations. Dis Colon Rectum. 2005; 48: 775-786. PMID: 15747078
27. Marini M, Bamias G, Rivera-Nieves J, Moskaluk CA, Hoang SB, Ross WG, et al. TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc Natl Acad Sci U S A. 2003; 100: 8366-8371. PMID: 12832622
28. Zeissig S, Bojarski C, Buergel N, Mankertz J, Zeitz M, Fromm M, et al. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut. 2004; 53: 1295-1302. PMID: 15306588
29. Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci. 1994; 107 (Pt 12): 3569-3577. PMID: 7706406
30. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 1993; 366: 701-704. PMID: 8259214
31. Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 2005; 65: 3980-3985. PMID: 15899785
32. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther. 2002; 1: 639-649. PMID: 12479224
33. Miller JP, Yeh N, Vidal A, Koff A. Interweaving the cell cycle machinery with cell differentiation. Cell Cycle. 2007; 6: 2932-2938. PMID: 18000404
34. Vidal A, Koff A. Cell-cycle inhibitors: three families united by a common cause. Gene. 2000; 247: 1-15. PMID: 10773440
35. Liu W, Chen Y, Golan MA, Annunziata ML, Du J, Dougherty U, et al. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J Clin Invest. 2013; 123: 3983-3996. doi: 10.1172/JCI65842 PMID: 23945234
36. Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J, et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008; 294: G208-216. PMID: 17962355
37. Butzner JD, Parmar R, Bell CJ, Dalal V. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut. 1996; 38: 568-573. PMID: 8707089
38. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993; 69: 238-249. PMID: 8350599
39. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994; 45: 491-503. PMID: 8198398
40. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003; 10: 45-65. PMID: 12655295
41. Joo YE, Karrasch T, Muhlbauer M, Allard B, Narula A, Herfarth HH, et al. Tomato lycopene extract prevents lipopolysaccharide-induced NF-kappaB signaling but worsens dextran sulfate sodium-induced colitis in NF-kappaBEGFP mice. PLoS One. 2009; 4: e4562. doi: 10.1371/journal.pone.0004562 PMID: 19234608
42. Li Y, Dowbenko D, Lasky LA. AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem. 2002; 277: 11352-11361. PMID: 11756412
43. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol. 2001; 3: 245-252. PMID: 11231573
44. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 2003; 13: 65-70. PMID: 12559756
45. Manapov F, Muller P, Rychly J. Translocation of p21(Cip1/WAF1) from the nucleus to the cytoplasm correlates with pancreatic myofibroblast to fibroblast cell conversion. Gut. 2005; 54: 814-822. PMID: 15888791
46. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, et al. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 1999; 18: 1223-1234. PMID: 10064589
47. Wu S, Liao AP, Xia Y, Li YC, Li JD, Sartor RB, et al. Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am J Pathol. 177: 686-697. doi: 10.2353/ajpath.2010.090998 PMID: 20566739
48. Gartel AL. The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis. Leuk Res. 2005; 29: 1237-1238. PMID: 15946739
49. Ghanem L, Steinman R. A proapoptotic function of p21 in differentiating granulocytes. Leuk Res. 2005; 29: 1315-1323. PMID: 15893818
50. Kraljevic Pavelic S, Cacev T, Kralj M. A dual role of p21waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate. Cancer Gene Ther. 2008; 15: 576-590. doi: 10.1038/cgt.2008.28 PMID: 18483502
51. Liu S, Bishop WR, Liu M. Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat. 2003; 6: 183-195. PMID: 12962684
52. Zhang Y, Wang Z, Magnuson NS. Pim-1 kinase-dependent phosphorylation of p21Cip1/WAF1 regulates its stability and cellular localization in H1299 cells. Mol Cancer Res. 2007; 5: 909-922. PMID: 17855660
53. Chen Y, Gu J, Li D, Li S. Time-course network analysis reveals TNF-alpha can promote G1/S transition of cell cycle in vascular endothelial cells. Bioinformatics. 2012; 28: 1-4. doi: 10.1093/bioinformatics/btr619 PMID: 22088844
54. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol. 2003; 171: 6164-6172. PMID: 14634132
55. Gitter AH, Bendfeldt K, Schulzke JD, Fromm M. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J. 2000; 14: 1749-1753. PMID: 10973924
56. Abreu MT, Palladino AA, Arnold ET, Kwon RS, McRoberts JA. Modulation of barrier function during Fas-mediated apoptosis in human intestinal epithelial cells. Gastroenterology. 2000; 119: 1524-1536. PMID: 11113074
57. Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology. 1999; 116: 301-309. PMID: 9922310
58. Yoon JH, Cho ML, Choi YJ, Back JY, Park MK, Lee SW, et al. Gastrokine 1 regulates NF-kappaB signaling pathway and cytokine expression in gastric cancers. J Cell Biochem. 2013; 114: 1800-1809. doi: 10.1002/jcb.24524 PMID: 23444260
59. Arai N, Mitomi H, Ohtani Y, Igarashi M, Kakita A, Okayasu I. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis. Mod Pathol. 1999; 12: 604-611. PMID: 10392637
60. Ioachim EE, Katsanos KH, Michael MC, Tsianos EV, Agnantis NJ. Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features. Int J Colorectal Dis. 2004; 19: 325-333. PMID: 15060836
61. Xing R, Li W, Cui J, Zhang J, Kang B, Wang Y, et al. Gastrokine 1 induces senescence through p16/Rb pathway activation in gastric cancer cells. Gut. 2012; 61: 43-52. doi: 10.1136/gut.2010.230623 PMID: 21676900
62. Yoon JH, Kang YH, Choi YJ, Park IS, Nam SW, Lee JY, et al. Gastrokine 1 functions as a tumor suppressor by inhibition of epithelial-mesenchymal transition in gastric cancers. J Cancer Res Clin Oncol. 2011; 137: 1697-1704. doi: 10.1007/s00432-011-1051-8 PMID: 21898090